Profound Medical

Profound Medical operates as a commercial-stage medical device firm built around TULSA-PRO, a platform that removes prostate tissue via MRI-guided robotics and closed-loop control. Its lead offering for prostate disease combines minimally invasive methods with AI, MRI guidance, and robotic precision, while Sonalleve, a CE-marked system, treats uterine fibroids non-invasively and eases bone-metastasis pain.

The system monitors temperature through real-time MRI and applies closed-loop feedback to regulate ablation energy during the procedure. Conducted on an outpatient basis, the TULSA Procedure provides men a prostate-disease treatment option distinct from surgery or radiation.